Marker Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Marker Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2024.
  • Marker Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$3.84M, a 36.9% decline year-over-year.
  • Marker Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$10.7M, a 30.3% decline year-over-year.
  • Marker Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$10.7M, a 30.3% decline from 2023.
  • Marker Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.24M, a 72.5% increase from 2022.
  • Marker Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29.9M, a 28.5% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$10.7M -$3.84M -$1.03M -36.9% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$9.7M -$2.31M +$674K +22.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$10.4M -$2.19M -$4.71M -187% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$5.66M -$2.39M +$2.57M +51.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$8.24M -$2.8M +$1.05M +27.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 -$9.29M -$2.98M +$3.94M +56.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$13.2M $2.52M +$11.8M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$25M -$4.97M +$4.94M +49.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$29.9M -$3.86M +$5.91M +60.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$35.8M -$6.92M +$5.51M +44.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$41.3M -$9.24M +$1.66M +15.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$43M -$9.91M -$1.13M -12.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$41.9M -$9.76M -$1.26M -14.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$40.6M -$12.4M -$5.06M -68.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$35.6M -$10.9M -$4.57M -72% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$31M -$8.78M -$2.29M -35.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$28.7M -$8.51M -$3.43M -67.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$25.3M -$7.37M -$1.91M -35% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$23.4M -$6.34M -$771K -13.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$22.6M -$6.49M -$1.17M -21.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$21.4M -$5.08M +$130M +96.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 -$152M -$5.46M -$1.07M -24.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$151M -$5.57M -$758K -15.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$150M -$5.32M -$2.12M -66.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$148M -$136M -$133M -4952% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$15.1M -$4.39M -$403K -10.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$14.7M -$4.81M -$2.92M -154% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$11.8M -$3.2M -$777K -32.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$11M -$2.68M -$1.11M -70.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$9.88M -$3.99M -$1.88M -89.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$7.99M -$1.89M -$7.87M -132% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$126K -$2.42M +$2.33M +49.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$2.46M -$1.58M +$75.9K +4.59% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 -$2.53M -$2.1M -$30.6M -107% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $28.1M $5.97M +$66.2M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$38.1M -$4.75M -$4.05M -578% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 -$34.1M -$1.65M -$1.29M -357% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$32.8M $28.5M +$30.1M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$62.8M -$60.2M -$61M -8092% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$1.88M -$701K +$29M +97.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$30.9M -$362K Oct 1, 2014 Dec 31, 2014 10-K 2016-04-14
Q3 2014 -$1.57M Jul 1, 2014 Sep 30, 2014 10-Q/A 2016-04-14
Q2 2014 $753K +$1.62M Apr 1, 2014 Jun 30, 2014 10-Q/A 2016-04-14
Q1 2014 -$29.7M -$29.3M -6630% Jan 1, 2014 Mar 31, 2014 10-Q/A 2016-04-14
Q2 2013 -$871K +$1.67M +65.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-18
Q1 2013 -$441K +$157K +26.3% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-21
Q2 2012 -$3.5M -$2.54M -$2.14M -529% Apr 1, 2012 Jun 30, 2012 10-Q/A 2012-09-12
Q1 2012 -$1.36M -$599K +$669K +52.8% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-08-19
Q4 2011 -$2.03M $487K Oct 1, 2011 Dec 31, 2011 10-K 2013-05-15
Q3 2011 -$844K +$170K +16.7% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-21
Q2 2011 -$404K +$935K +69.8% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-12
Q1 2011 -$1.27M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 -$1.01M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$1.34M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.